2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Kidney Diseases in 2 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, B | 1 |
| Deng, Q | 1 |
| Zhang, L | 1 |
| Zhu, W | 1 |
| Shaik, ZP | 1 |
| Fifer, EK | 1 |
| Nowak, G | 1 |
2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Kidney Diseases
| Article | Year |
|---|---|
Nobiletin alleviates ischemia/reperfusion injury in the kidney by activating PI3K/AKT pathway.
Topics: Animals; Apoptosis; Caspase 12; Chromones; Endoplasmic Reticulum Stress; Flavones; Kidney; Kidney Di | 2020 |
Akt activation improves oxidative phosphorylation in renal proximal tubular cells following nephrotoxicant injury.
Topics: Adenosine Triphosphate; Animals; Cells, Cultured; Chromones; Cysteine; Electron Transport; Electron | 2008 |